Skip to main content

The history of CellaVision

You can follow our development into the international group we have become by looking at some of our most important milestones.

In 1994, CellaVision was founded in Lund, Sweden with a vision to elevate healthcare through the evolution of microscopy. The journey from a small startup to a global leader in digital microscopy is marked by continuous innovation, strategic expansion, and a commitment to improving diagnostic accuracy and efficiency in clinical laboratories. 

Improved connectivity
A selection of CellaVision hardware products

First successful devices

From the early 2000s onward, CellaVision has produced several innovative devices and software to help laboratories improve the efficiency and quality of their work.

In 2008, CellaVision launches the Body Fluid Application.
In 2010, CellaVision launches the DM1200.  
In 2013, the CellaVision Proficiency Software and the Sysmex DI-60 are launched.  
In 2014, CellaVision launches the DM9600 and the CellaVision Advanced RBC software.  

Inauguration RAL

Expansion into new areas

In 2015, CellaVision Academy, an online training resource, is introduced.

In 2018, CellaVision was listed on the NASDAQ Stockholm, Mid Cap.  

In 2019, CellaVision acquires RAL Diagnostics, providing the company with the ability to further improve the quality of sample preparation. RAL supplies innovative products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing.   

The early years of RAL Diagnostics

1916 In 1916, RAL Diagnostics was founded 
by two collaborators of Louis 
Pasteur: Pr. Roux & Legroux and 
M. Agulhon, Director of Kuhlman industries.
Louis Pasteur
1960 In 1960, RAL joins Rhône-Poulenc.
Following a number of mergers in 
the chemistry field, 
RAL Diagnostics joins the health-care
division of Rhône-Poulenc group (Aventis).
1996 RAL Diagnostics becomes independent
and transfers its production facilities 
to Martillac, France.
RAL production facilities
DC-1 and screen displaying cells

Launch of the DC-1

In 2019, CellaVision launches the DC-1, a smaller analyzer that has been custom-designed to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell differential.


Recent developments

In 2021, CellaVision acquires the exclusive rights to a patent portfolio on Fourier Ptychographic Microscopy (FPM) from Clearbridge BioPhotonics.  

The same year, CellaVision launches the DIFF-Line, a complete workflow solution for low-volume hematology laboratories.